Clinical Investigators' Financial Disclosures May Become Public Under FDA Draft Guidance
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA draft guidance, which includes many concepts recommended by HHS OIG, replaces document finalized in 2001.